Immunotherapy combination promising for untreated patients with advanced melanoma

20 abril 2015

The combination of two immunotherapies for first-line treatment of advanced melanoma induces better responses and far longer progression-free survival than giving one of those drugs alone, new research shows. Further, the combination was effective in the portion of melanoma patients–the majority–who currently have few effective treatment options.